Mason Co:LAB for Science and Innovation 2019

Panel # 1: Merging Life Science & Data in and out of the Lab

Moderator: Neil Lamb, Ph.D., Vice President of Educational Outreach & Faculty Investigator, HudsonAlpha

Dr. Neil Lamb leads the Educational Outreach team at the HudsonAlpha Institute for Biotechnology in their endeavor to cultivate a more genomically-literate society and to inspire and train tomorrow’s biotechnology workforce. This past year, more than 1.2 million students, educators, practitioners and members of the general public were impacted by his team’s efforts. Prior to joining HudsonAlpha in 2006, Neil was a faculty member in the Department of Human Genetics at Emory University’s School of Medicine. While there, his career shifted from hands-on research to science education after realizing that he found his true calling: inspiring a passion for genetics and biotechnology in others. In 2018, Neil’s contributions to the advancement of science education earned him the Faraday Science Communicator Award from the National Science Teachers Association. More recently, he was appointed by Governor Kay Ivey to chair the Governor’s Advisory Council for Excellence in STEM, which brings together educators, representatives of government, and business and industry leaders to develop Alabama’s ‘Roadmap to STEM Success.’ Neil and his wife, Cynthia, have three children, whom he considers to be his most fulfilling genetic achievement.

Kavita Bhat, Ph.D., Executive Director of Laboratory Operations, Myriad Neuroscience

As Executive Director of Laboratory Operations, Kavita plays a key role in planning, developing, and directing all aspects of Myriad Neuroscience laboratories. Prior to her role with Myriad, she served as the Vice President of Laboratory Operations at AKESOgen, Inc. in Georgia. While there, she was responsible for the US laboratory operations and strategically built the lab team from 12 employees to over 30 employees within 2 years. She is also a licensed Clinical Laboratory Director in the State of NY and Georgia which gives her the ability to oversee clinical testing, test validation and overall operations. Kavita is well versed in state and federal regulations including CLIA and CAP, and has a Ph.D. in Cellular Molecular Biology and Physiology from Georgia State University and holds a Lean Six Sigma White belt in Healthcare.

Andrew Marshak, Director of Product Development, Myriad Neuroscience

As Director of Product Management for Myriad Neuroscience, Andrew provides strategic direction for the current product portfolio as well as new product evaluation and planning.  Andrew brings 10 years of experience creating and executing 5-year company strategic plans, developing and managing product portfolios through the product lifecycle, and building and training multidisciplinary teams. Andrew earned his B.A. in Sociology with a minor in Economics from Pitzer College.

Manny Setegn, Chief Technology Officer and Co-Founder, Genetesis

Manny manages sustained and new product development at Genetesis, working together with many engineering disciplines to deliver the highest quality medical devices. He most recently studied Computer Science and Engineering and Economics at The Ohio State University.

Robert Sokolowski, Ph.D., MBA, Vice President Clinical, Quality and Regulatory, Genetesis

Robert Sokolowski earned his Ph.D. in Materials Engineering from Rensselaer Polytechnic Institute and an MBA from Fairleigh Dickinson University. In his early career he developed methods to produce amorphous metals and superconductors on a commercial scale. At NASA he served as the scientific head of two international Spacelab missions leading to new understanding in the materials and life sciences. For the past 20 years he has devoted his energy to bringing some novel exciting medical devices into the global marketplace.

Panel # 2: A Conversation About Genomic Pathways – How Did We Get Here and Where Are We Going

Neil Lamb, Ph.D., Vice President of Educational Outreach & Faculty Investigator, HudsonAlpha

Sandra Gunselman, Ph.D., Executive Director, Advanced Diagnostics Lab, National Jewish Health

Sandra Gunselman, PhD, currently serves as the Executive Director of the Advanced Diagnostics Laboratories, leading the effort to expand business for the laboratories and market specialized diagnostic tests to larger audiences. National Jewish Health Advanced Diagnostic Laboratories provides immune and respiratory disease expertise to clinical, biotech, pharmaceutical, public health and diagnostic partners. Prior to joining National Jewish Health, she was Vice President of Laboratory Operations with Assurex Health. Dr. Gunselman received her doctorate in cellular and molecular biology from Colorado State University and completed postdoctoral fellowships at the University of Washington and Eppley Cancer Research Center in Omaha, Nebraska. Additionally, she has authored 18 peer-reviewed publications.

Panel # 3:  Innovation and Mason’s Entrepreneurship Ecosystem

Moderator: Mark Verratti, President, Myriad Neuroscience

With over 25 years of experience delivering consistent and reliable revenue growth in the healthcare industry, Mark Verratti currently serves as President of Myriad Neuroscience. Prior to his current rold, he served as Senior Vice President, Chief Sales and Business Development Officer. As an industry leader in the medical and pharmaceutical sales profession, Mark brings valuable insights into the development of innovative sales strategies, product portfolio management, key account growth, problem-solving, talent development and analytics. Mark’s proven leadership is reflected in his numerous positions and promotions including his previous time at Cyberonics, where over five years he doubled global revenues. These results were achieved due to Mark’s vast knowledge of all aspects of commercial leadership including sales cycle, business development and the implementation of global sales, commercial strategies, customer service and sales training. Mark earned a B.S. in Life Sciences with a minor in Physiology from The Pennsylvania State University.

Ryan Eder, Chief Executive Officer and Founder, Include Health

Ryan Eder is the founder and CEO of IncludeHealth™, a digital health & wellness company that pairs HIPAA compliant cloud software with inclusive rehabilitation equipment to optimize care. IncludeHealth’s transformative design and technology connects patients, providers and payers to streamline delivery while harvesting objective measurable data creating actionable insights for outcomes.

Tim Raderstorf, Chief Innovation Officer, OSU College of Nursing

TIm Raderstorf if the first Chief Innovation Officer at The Ohio State University College of Nursing, the #1 public nursing college in the nation. During his time in healthcare, he has studied and focused on neurosurgical research on Tethered Spinal Cord Syndrome, skilling the healthcare workforce in India, developing Innovation curriculum, designing clinical spaces, improving patient throughput in the pediatric hematology/oncology ambulatory settings, promoting patient safety and satisfaction in one of the nation’s largest Emergency Departments, transitioning organizations into new physical locations, and developing novel commercial innovations to enhance patient outcomes. He is the proud founder of The Innovation Studio, a moveable makerspace Frankensteined together with an incubator to promote interprofessional collaboration at The Ohio State University. The Innovation Studio combines his passions of connecting great people and fostering ideation through the innovation and commercialization process.

Peeyush Shrivastava, Chief Executive Officer and Co-Founder, Genetesis

Peeyush is a technology entrepreneur and executive with 6 years of experience building healthcare technology startups that optimize patient and physician workflows. He is currently the President and CEO of Genetesis, a medical technology company developing a proprietary biomagnetic imaging device and fully connected web services platform. Prior to Genetesis, Peeyush served as Chief Strategy Officer for Proscia, a digital pathology informatics company leveraging deep learning and cloud technologies to optimize pathologist workflows. Peeyush was pursuing a degree in Biomedical Science at The Ohio State University, but took a leave of absence after accepting the Thiel Fellowship in 2017. To date, Peeyush has raised $10 million in venture capital and grants and is a listed inventor on several patents.